Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease. Here we answer common questions about the latest vaccines.
Q&A on the Updated COVID-19 Vaccines
Background Science
Q&A on Mpox
Last summer saw the largest outbreak ever of mpox, the disease formerly known as monkeypox. Here, we provide an update on the disease, and explain what makes the outbreak unusual and how people can protect themselves.
What VAERS Can and Can’t Do, and How Anti-Vaccination Groups Habitually Misuse Its Data
For decades, the Vaccine Adverse Event Reporting System, or VAERS, has been exploited by people opposed to vaccination. Here, we’ll explain how VAERS works and run through five misconceptions that anti-vaccination activists wield to mislead people about vaccines.
Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect Infants
Nearly all children get sick from respiratory syncytial virus, or RSV, by the age of 2, and last year, there was a notable surge in RSV-associated hospitalizations. But the Food and Drug Administration is now considering approval of a vaccine and a monoclonal antibody aimed at protecting infants from this common virus.
Q&A on RSV Vaccine Candidates for Older Adults
This year, the Food and Drug Administration will consider several applications for vaccines and a monoclonal antibody to prevent respiratory syncytial virus, or RSV, illness. We’ll go through some common questions about RSV and the potential vaccines for older adults in this story.
Q&A on Omicron-Updated COVID-19 Boosters
Retooled COVID-19 booster vaccines that target omicron subvariants of the coronavirus are now available in the U.S. Here, we answer questions about the new shots.
A Guide to Novavax’s COVID-19 Vaccine
After a long delay marred by manufacturing troubles, a COVID-19 vaccine from Novavax became the fourth such vaccine authorized in the U.S. We review how it works and how it’s different from its competitors.
Q&A on Financial Disclosures by Government Scientists
In this story, we’ll explain what we know about the financial and conflict-of-interest disclosure requirements for Dr. Anthony Fauci, other National Institutes of Health higher-ups and members of two U.S. vaccine advisory committees.
A Guide to COVID-19 Vaccines for the Youngest Kids
Children under 5, including those as young as 6 months of age, are now able to be vaccinated against COVID-19. Here, we explain what’s known about the two coronavirus vaccines for the youngest children.
COVID-19 Vaccines Don’t Contain Fetal Tissue
Despite persistent claims to the contrary, none of the three authorized or approved COVID-19 vaccines contains fetal tissue. We take a look at the facts in light of Justice Clarence Thomas’ dissent.